Cresset Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cresset Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.44M	Buy	34,384 +3,797	+12%	+$513K	0.02%	393
2026 Q1	$3.91M	Buy	30,587 +12,092	+65%	+$1.51M	0.02%	415
2025 Q4	$2.26M	Buy	18,495 +61	+0.3%	+$6.99K	0.01%	531
2025 Q3	$1.85M	Buy	18,434 +8,735	+90%	+$787K	0.01%	558
2025 Q2	$804K	Buy	9,699 +3,223	+50%	+$257K	﹤0.01%	751
2025 Q1	$525K	Buy	6,476 +3,797	+142%	+$339K	﹤0.01%	1043
2024 Q4	$241K	Sell	2,679 -1,441	-35%	-$140K	﹤0.01%	1466
2024 Q3	$407K	Sell	4,120 -7,193	-64%	-$707K	﹤0.01%	1641
2024 Q2	$1.05M	Buy	+11,313	New	+$1.01M	﹤0.01%	1038
2024 Q1	–	Sell	-35,920	Closed	-$3.21M	–	1995
2023 Q4	$3.21M	Buy	35,920 +5	+0%	+$371	0.02%	424
2023 Q3	$2.62M	Sell	35,915 -3,445	-9%	-$275K	0.01%	463
2023 Q2	$3.27M	Buy	+39,360	New	+$3.29M	﹤0.01%	513

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Cresset Asset Management's XBI Position: Q2 2026 in Review

Cresset Asset Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 12% in Q2 2026, buying an estimated $513K and bringing the position to 34,384 shares worth $5.44M. The position accounts for 0.02% of the portfolio, ranked #393.

Cresset Asset Management first reported a position in XBI in Q2 2023 and has held it in 12 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Cresset Asset Management held 34,384 shares of State Street SPDR S&P Biotech ETF worth $5.44M as of Q2 2026.
Cresset Asset Management bought 3,797 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $513K.
State Street SPDR S&P Biotech ETF made up 0.02% of Cresset Asset Management's portfolio in Q2 2026, its #393 holding.
Cresset Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 12 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.